Insider Transactions in Q1 2024 at Clearside Biomedical, Inc. (CLSD)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2024
|
Ngai Hang Victor Chong Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$30,000
$1.6 P/Share
|
|
Feb 07
2024
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
444,444
+9.0%
|
$444,444
$1.35 P/Share
|
|
Jan 19
2024
|
Charles A. Deignan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,900
-3.24%
|
$12,900
$1.28 P/Share
|
|
Jan 19
2024
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
18,000
-3.71%
|
$18,000
$1.27 P/Share
|